Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Guinea-Bissau
Guinea-Bissau: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 90.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Guinea-Bissau, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Guinea-Bissau is 90.0%, measured in 2025. That is the highest value across all 18 years on record.
The figure is up 800.0% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Guinea-Bissau peaked at 90.0% in 2023 and was at its lowest, 0.0%, in 2008.
That places Guinea-Bissau 70th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 34.1% | 0.0% | 85.0% | 10 |
| 2020s | 85.5% | 74.0% | 90.0% | 6 |
Countries ranked near Guinea-Bissau
More health data for Guinea-Bissau
- Heat deaths vs projected death rates 1,070 (2090)
- Un projection of annual infant deaths 941 (2100)
- Deaths in armed conflicts by region 0 (2026)
- Deaths in armed conflicts by country 0 (2026)
- Age population, age 08, male, interpolated 28,594 (2025)
- Population, male 49.4% (2025)
- Population ages 15-64, female 666,780 (2025)
- Population ages 0-14, total 862,130 (2025)
- Age population, age 06, female, interpolated 28,214 (2025)
- Age population, age 06, male, interpolated 28,958 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Guinea-Bissau?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Guinea-Bissau was 90.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Guinea-Bissau?
- The highest recorded value was 90.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Guinea-Bissau?
- The lowest recorded value was 0.0% in 2008.
- How does Guinea-Bissau rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Guinea-Bissau ranks 70th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Guinea-Bissau?
- Over the last ten years it is up 800.0%. The long-run trend across the full record is volatile.
- Where does this Guinea-Bissau data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).